skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi 5i team,
Earlier in April they announced a financing deal and the stock price has been going lower ever since. On April 23 they announced a new dividend of .03 cents which means a DY of about 2%. It's not spectacular, but we like the 'confidence' that a dividend announcement brings, no? How long before the market reacts to this? Specifically, shouldn't some fund managers and institutional players jump onboard soon after, when there is a new dividend announcement for this stock? (and a corresponding uptick in the price). Thx, R.
Read Answer Asked by Robert on May 02, 2018
Q: Edwards, a US company that you likely do not follow, has developed an minimally invasive medical device and procedure for replacing faulty valves in humans. This procedure has many advantages, includinding cost and recovery time, over the open heart procedure. While there is competition in this market Edwards appears to be growing the stock has not performed well recently and I am down about 8%. I am considering selling if my loss reaches 10%.
Would you please give me you opinion of this company if you follow it t all?
With appreciation,
Ed
Read Answer Asked by Ed on May 01, 2018
Q: Hi guys,

Which stocks do you think have the potential to become 5, 10, or even 20 baggers over time? Would PBH, SIS, and PBL be on the list (or has their time past)? Also, can you rank the three in terms of which have the most growth going forward?

Thanks in advance.
Read Answer Asked by John on April 24, 2018
Q: Hi, I have a 1/3 position in Allergan (AGN), down about 40%. Michael Waterhouse, a Morningstar analyst, makes a strong case that Allergan is considerably undervalued. I’m thinking of adding to my position and would appreciate your opinion. I also hold full positons in GILD, CSH.UN and GUD, as part of a well-diversified portfolio.
Thanks, Kevin
Read Answer Asked by Kevin on April 23, 2018
Q: My local newspaper had an enlightening article on opioid prescriptions to treat chronic pain. The article stated that over 9 million prescriptions were filled "in Ontario alone" during 2015-2016. I found this number astounding considering the population is about 14 million which means one in every three people had this prescribed during that time which was an increase of 500,000 from three years previous to those dates.
Does this not mean Knight's announcement of Health Canada's approval of Probuphine for opioid treatment is a huge event? Why would they announce this after the close on a Friday - it seems like a big deal. What do you think?
Read Answer Asked by Steven on April 23, 2018
Q: Just received report and the board would like to list on Nasdaq exchange.They want to reduce share holdings for a price to stay listed on exchange.Good or bad and should I buy more or wait for more results.I could buy 1000 shares and wait also.Very small % of portfolio
Read Answer Asked by Guy on April 20, 2018
Q: News reports say Takeda is offering $66.20 in cash and stock for SHPG but stock currently trades at $160.16. Am I missing something? Aside from the takeover interest, is SHPG a good buy at this time
Read Answer Asked by hal on April 20, 2018
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!